用双边肺密封剂治疗的严重肺:一个长期随访的病例系列
Cecilia Lindnér1, Kristine Jensen2, Jann Mortensen3,4
1Department of Thoracic and Cardiovascular Surgery, Heart Center, Copenhagen, Denmark.
Biomedicine hub
|July 5, 2023
概括
肺膜密封剂 (ELS) 为肺提供支气管镜肺体积减小,改善肺功能和症状长达五年. 然而,它没有证明生存益处,需要进一步研究患者选择.
科学领域:
- 肺部病理学 肺部病理学
- 干预性肺病学 干预性肺病学
- 生物材料在医学中的应用
背景情况:
- 支气管镜肺体积减小 (BLVR) 是治疗肺气的手术肺体积减小 (LVRS) 的一种不断发展的替代方案.
- 肺膜密封剂 (ELS) 针对具有附带通风 (CV) 的患者,显示改善肺功能的希望.
- 之前的研究表明,ELS在长达两年的时间内获得了良好的结果.
研究的目的:
- 介绍一系列病例,包括四名双边接受ELS治疗的肺气患者.
- 评估ELS长期疗效和安全性,治疗后长达6年.
- 评估肺功能变化,主观症状和患者结果.
主要方法:
- 四名患有肺气的患者接受了双边ELS治疗.
- 两名患者之前有LVRS和BLVR与门.
- 随访时间延长至6年,包括螺旋计和COPD评估测试 (CAT) 成绩.
主要成果:
- 所有患者在ELS后表现出改善的螺旋计值,持续时间从一年到五年不等.
- 三名患者报告主观症状改善 (CAT分数),其中一名患者经历了超过五年的持久益处.
- 两名患者经历了反复的恶化和肺炎,需要在一年和三年内进行肺移植.
结论:
- 在肺瘤患者中,ELS有效降低了高通胀,并改善了肺功能和呼吸障碍症状,长达五年.
- 可能会出现复发症,如反复恶化,可能导致肺移植.
- 需要进一步的研究来确定ELS的最佳候选人,并有效地管理CV阳性患者.
相关概念视频
Pneumothorax-II
214
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
214
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Flail Chest-II
210
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
210
COPD: Management Using Bronchodilators and Corticosteroids
250
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
250
Acute Respiratory Failure-V
166
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
166
Mechanical Ventilation III: Noninvasive Ventilation
154
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
154


